Google News

SK Biopharmaceuticals signs $795 million licensing deal with Biohaven for epilepsy drug - Korea JoongAng Daily

Aug 26, 2026, 3:19 AM

Translate article text

Choose a language and wait for the translated text.

SK Biopharmaceuticals signs $795 million licensing deal with Biohaven for epilepsy drug  Korea JoongAng Daily